Cargando…
Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis
Abaloparatide (previously known as BA058) is a synthetic 34-amino acid peptide and novel selective activator of parathyroid hormone receptor 1 (PTHR1) currently under development as a new anabolic agent in the management of osteoporosis. This paper reviews the profile and potential of abaloparatide...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493470/ https://www.ncbi.nlm.nih.gov/pubmed/28680788 http://dx.doi.org/10.7759/cureus.1300 |